Navigation Links
Raptor Pharmaceutical Corp. Announces Publication of Results from Phase 2a Trial of DR Cysteamine for Treatment of Cystinosis
Date:1/11/2010

(<2 nmol half-cystine/mg protein) in subjects with cystinosis. Results also indicated that the prototype DR Cysteamine effectively maintained trough WBC cystine levels within a satisfactory range when patients received approximately 60% of the previous total daily dose of IR Cysteamine.

Dr. Dohil stated, "We are seeking to improve tolerability and reduce dosing frequency requirements of IR Cysteamine which have been documented challenges for cystinosis patients, leading to widely reported instances of poor treatment compliance. We believe the results of the Phase 2a study bring us significantly closer to a potential treatment solution for cystinosis patients. The results from our trial indicate prototype delayed-release cysteamine formulation lead to improved tolerability and efficacy when administered twice-daily and at a lower total daily dose than IR Cysteamine. Based on these results, I believe that Raptor's final DR Cysteamine formulation has the potential to improve compliance and long-term treatment outcomes for cystinosis patients."

Based on these Phase 2a results, Raptor conducted a Phase 2b clinical trial using its final commercial formulation of DR Cysteamine and recently announced the following top-line Phase 2b results: DR Cysteamine demonstrated improved tolerability and the potential to reduce total daily dosage and administration frequency compared to IR Cysteamine.

  • Pharmacokinetic evaluation showed that DR Cysteamine had a terminal half-life more than three times longer than the terminal half-life of IR Cysteamine.
  • Twice-daily DR Cysteamine may achieve the same pharmacodynamic result while using a total daily dose 30% lower than IR Cysteamine administered four times daily.
  • No adverse events recorded during the clinical trial were determined by the principal investigator to be possibly or probably related to DR Cysteamine. Nine adverse events recorded in the clinical trial were determined to
    '/>"/>

SOURCE Raptor Pharmaceutical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Raptor Pharmaceuticals Provides Update of Product Programs
2. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
5. Raptor Pharmaceuticals Provides Update on Targeting Platforms
6. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
7. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
8. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
9. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
10. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
11. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... CHENGDU, China , Dec. 23, 2014 /PRNewswire/ ... a pharmaceutical company that specializes in patented biopharmaceutical, ... active pharmaceutical ingredients (API) today announced that the ... for its Good Manufacturing Practice (GMP) certificate of ... & Drug Administration,s (CFDA). The public notice period ...
(Date:12/22/2014)... JUNCTION, N.J. , Dec. 22, 2014 /PRNewswire/ ... company marketing its CytoSorb® blood purification technology to ... surgery patients in 28 countries worldwide, today announced ... Russo , MD, FACS, as its Senior Vice ... Dr. Di Russo ...
(Date:12/22/2014)... Dec. 22, 2014   TRU-D SmartUVC LLC, ... disinfection robot, announced today that the General Services Administration ... November 2019.   This newly formed agreement ... levels of government purchasers, including Department of Veteran Affairs ... Homeland Security contacts purchasing solutions for the Ebola effort ...
Breaking Medicine Technology:TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2
(Date:12/24/2014)... For chic ladies, new fashionable outfits are ... of their Holiday Wish List, Angeldress.co.uk has chosen ... to accent ladies’ holiday wardrobe by launching a promotion on ... over the discount of 80% off, like a cheap suit. ... The company’s chic wedding dresses are among the hottest items ...
(Date:12/24/2014)... The 2014 Market Research Report ... in-depth research report on COC industry. For an ... including its definition, classification, application, industry chain structure, ... report also presents product specification, manufacturing process, and ... regions, technology and applications. Analysis also covers upstream ...
(Date:12/24/2014)... December 24, 2014 Verde Pointe Dental Associates ... ever. "Last years homemade Christmas sweater lit up, but ... The 2014 winner is Tandy Wilson for the second year ... enthusiast," says Kirk Kimmerling DDS. "She took pictures of the ... the sweater." , "Every year I enjoy stopping ...
(Date:12/24/2014)... 24, 2014 “ Relax Melodies ” ... AppWatch, which features the latest and coolest mobile applications ... a mobile technology expert and host of NewsWatch, conducted ... application soothes users so they can fall asleep. , ... adults say they have some sort of difficulty sleeping. ...
(Date:12/24/2014)... Aliso Viejo, California (PRWEB) December 24, 2014 ... the release of the ProDenoise from Pixel Film Studios. , ... film noise or grain in their footage,” said Christina Austin, ... to have in any Final Cut Pro X editors toolbox.” ... subdue film noise or grain in their footage with ProDenoise ...
Breaking Medicine News(10 mins):Health News:Angeldress.co.uk Starts Its Big Sales by Offering Various Kinds of Cheap Clothes and Fashion Accessories 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3Health News:Verde Pointe Dental Associates Announces the 2014 Ugly Sweater Holiday Contest Winner 2Health News:An Application to Help with Insomnia was Featured on NewsWatch Television on December 19, 2014 2Health News:Pixel Film Studios released the ProDenoise plugin for Final Cut Pro X today. 2
... Pa., Oct. 15 ViroPharma Incorporated,s (Nasdaq: VPHM ) ... released on Wednesday, October 28, 2009 before the open of ... conference call and live audio webcast at 9:00 a.m. Eastern ... ViroPharma management will discuss the 2009 third quarter and other ...
... ROCHESTER, Minn., Oct. 15 Mayo Clinic clinicians and ... and tested a tool to involve patients more in ... set of decision aid cards, could help patients make ... outcomes. The results of this randomized trial are in ...
... UV radiation, researchers say , THURSDAY, Oct. 15 ... are better than yellow at protecting skin against damaging ... scientists. , The researchers said their findings could lead ... The color of fabric is one of the most ...
... Passes Veterans Health Care Budget Reform and Transparency Act of ... Federation of Government Employees, today, lauded the efforts of Congress ... health care provided by the Department of Veterans Affairs. For ... in the VA funding process. AFGE applauds these members of ...
... , FAIRFAX, Va., Oct. 15 Four ... new, non-profit association, the Association of Gamete Donor Providers ... to share information and services, enhance educational programs and ... involved in all aspects of building families with the ...
... companies have been doing it for years. Why not ... thoughtful discussion in hospitals and as a way to ... secondary markets. One developer, North Carolina-based Oaks ... medical office buildings (MOBs). As such, the innovative developer ...
Cached Medicine News:Health News:ViroPharma to Release 2009 Third Quarter Financial Results on October 28, 2009 2Health News:Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 2Health News:Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 3Health News:Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 4Health News:VA Funding Reform Bill Clears Congress 2Health News:Oaks Development Group Launches Physician Incubator Space in Palm Coast Medical Office Building 2
... Modes of Operation: , Standby: All toggle switches ... 60-ms bursts of 50 Hz separated by .75 s; ... pulse/s); single or repeat , Tetanus: 50 Hz ... Single (4 pulses/2 s); repeat (4 pulses/2 s; repeats ...
... of Operation: , Standby: All toggle switches at ... (1 pulse/s); 10 s (1 pulses/10 s) , ... (100 pulses/s) , Train-Of-Four: Single (4 pulses/2 s); ... , Output Current: Adjustable from 0-70 mA(HI range) ...
... of Operation: , Double Burst : 2 60-ms bursts ... 1 s (1 pulse/s) , Tetanus: 50 Hz ... Train-Of-Four: Single (4 pulses/2 s) , Output Current: Adjustable ... Monophasic pulses (200-us duration) , Indicators: Battery LED (green) ...
... standby switch maintains power to the instrument without ... pulse/s) , Tetanus: 100 Hz (200 pulses/s) ... Current: Adjustable from 0-70 mA , Stimulus ... Indicators: Battery LED (green) indicates that the units ...
Medicine Products: